ArticleJHEP reports : innovation in hepatology2023

Immuno-genomic-radiomics to predict response of biliary tract cancer to camrelizumab plus GEMOX in a single-arm phase II trial.

Qiu-Ping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.